Results 41 to 50 of about 622 (125)
Comparing the Performance of NoSQL Approaches for Managing Archetype-Based Electronic Health Record Data. [PDF]
PLoS ONE, 2016 This study provides an experimental performance evaluation on population-based queries of NoSQL databases storing archetype-based Electronic Health Record (EHR) data. There are few published studies regarding the performance of persistence mechanisms for
Sergio Miranda Freire +5 more
doaj +1 more source
Semantic Architecture for Interoperability in Distributed Healthcare Systems
IEEE Access, 2022 Electronic Health Records (EHRs) aggregate the entire patient’s data from different systems. Achieving interoperability for distributed EHR systems is expected to improve patient safety and care continuity, and therefore it improves the healthcare
Ebtsam Adel +4 more
doaj +1 more source
The ISO/EN 13606 Standard for the Interoperable Exchange of Electronic Health Records
Journal of Healthcare Engineering, Volume 2, Issue 1, Page 1-24, 2011., 2011 The standardization of Electronic Health Records (EHR) is a crucial factor for ensuring interoperable sharing of health data. During recent decades, a plethora of initiatives ‐ driven by international organizations ‐ has emerged to define the required models describing the exchange of information between EHRs.
Pilar Muñoz +5 more
wiley +1 more source
A Scalable Data Access Layer to Manage Structured Heterogeneous Biomedical Data. [PDF]
PLoS ONE, 2016 This work presents a scalable data access layer, called PyEHR, designed to support the implementation of data management systems for secondary use of structured heterogeneous biomedical and clinical data.
Giovanni Delussu +3 more
doaj +1 more source
Artificial Intelligence for Bone: Theory, Methods, and Applications
Advanced Intelligent Discovery, Volume 2, Issue 3, June 2026.Advances in artificial intelligence (AI) offer the potential to improve bone research. The current review explores the contributions of AI to pathological study, biomarker discovery, drug design, and clinical diagnosis and prognosis of bone diseases. We envision that AI‐driven methodologies will enable identifying novel targets for drugs discovery. The
Dongfeng Yuan +3 more
wiley +1 more source
Applications of Temporal Reasoning to Intensive Care Units
Journal of Healthcare Engineering, Volume 1, Issue 4, Page 615-636, 2010., 2010 Intensive Care Units (ICUs) are hospital departments that focus on the evolution of patients. In this scenario, the temporal dimension plays an essential role in understanding the state of the patients from their temporal information. The development of methods for the acquisition, modelling, reasoning and knowledge discovery of temporal information is,
J. M. Juarez +4 more
wiley +1 more source
Health Informatics Journal, 2021 Heterogeneities in data representation and care processes create interoperability complexity among Electronic Health Record systems (EHRs). We can resolve such data and process level heterogeneities by following consistent healthcare standards like ...
Suresh Kumar Mukhiya, Yngve Lamo
doaj +1 more source
Journal of Evaluation in Clinical Practice, Volume 32, Issue 2, March 2026.ABSTRACT Rationale Ubiquitous devices such as smartphones, wearables, and personal gadgets generate large volumes of personalized health data outside of traditional health systems. Despite its abundance, differences in data formats and semantics across hardware, platforms and sectors keep information siloed.
Keaton Banik +3 more
wiley +1 more source
BMC Medical Informatics and Decision Making, 2021 Background Ensuring data is of appropriate quality is essential for the secondary use of electronic health records (EHRs) in research and clinical decision support.
Qi Tian +5 more
doaj +1 more source
Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes
Annals of Human Genetics, Volume 89, Issue 5, Page 398-405, September 2025.ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott +3 more
wiley +1 more source